Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ivermectin not beneficial to symptom resolution in mild COVID-19 patients

europeanpharmaceuticalreviewMarch 08, 2021

Tag: Ivermectin , COVID-19 , clinical trial

PharmaSources Customer Service